Company profileNutraceutical & supplements#341 of 1,318 in Pakistan✓ No DRAP alerts

Medicom Superior, Lahore

Nutraceutical & supplement manufacturer · 52 registered products

Ranked #104 of 137 companies in Anti-Infectives

52 registered products 2 distinct molecules 0 DRAP alerts
52 of this company's registrations sit in the DRAP category “Nutritional Supplement / Multivitamin”, which is registered as a category rather than by molecule — so a low molecule count reflects how supplements are registered, not a small portfolio. Nutraceutical manufacturers advertise direct to consumers and are among the largest marketing spenders in the Pakistani market.

Company overview

52
registered products
2
distinct molecules
1
therapeutic classes
0
DRAP alerts

Medicom Superior, Lahore is a nutraceutical and dietary-supplement manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 52 product registrations. Its portfolio is concentrated in Anti-Infectives. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Top molecules by brand count

Nutritional Supplement / Multivitamin52 brands

Therapeutic classes

Anti-Infectives · 1

Conditions treated

URINARY TRACT INFECTION · 1

Price band (DRAP official ceilings)

Registered products priced by source
DVAGO1 products · Rs 61.52 – Rs 61.52
Servaid1 products · Rs 382.7 – Rs 382.7
Median across source: Rs 382.7

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

PharmEvo Private Limited1 shared molecules
C.C.L (Pvt) Ltd .1 shared molecules
HILTON PHARMA (PVT) LIMITED1 shared molecules
MATRIX PHARMA1 shared molecules
Hinucon1 shared molecules
Emmess Nutraceuticals1 shared molecules

Get the full profile for Medicom

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.